Concepedia

Residual Disease Coding

Residual Disease Coding is a neoplasm coding framework that classifies the persistence of malignant cells following therapeutic intervention, distinguished by its focus on post-treatment disease burden for prognostic and staging purposes.

37

Publications

2.5K

Citations

292

Authors

113

Institutions

Publications per year

2017–2026

10

Parents

Publications

37

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

M. J. Brisco, John T. Condon, Elizabeth Hughes et al. · The Lancet · 1994 · 274 citations

, , +16

Residual mass in lymphoma may not be residual disease.

George P. Canellos · Journal of Clinical Oncology · 1988 · 223 citations

, , +13

A framework for understanding and targeting residual disease in oncogene-driven solid cancers

Trever G. Bivona, Robert C. Doebele · Nature Medicine · 2016 · 188 citations · Full text

, , +14

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

Andreas Hochhaus, Andreas Reiter, Heyko Skladny et al. · Blood · 1996 · 173 citations · Full text

, , +14

The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease.

Gerald M. Lawrie, G. C. Morris, Abraham Silvers et al. · Circulation · 1982 · 143 citations

, , +14

1–5 of 37

Authors

292

  1. SJ
    Stuart J. Schnitt

    Harvard University, United States

    2 publications · 54 citations

    2

    h-index

  2. NS
    Neil S. Horowitz

    Brigham and Women's Hospital, United States

    2 publications · 116 citations

    2

    h-index

  3. DS
    D.M. Sibbering

    Nottingham City Hospital, United Kingdom

    1 publications · 14 citations

    1

    h-index

  4. EY
    Evan Y. Yu

    University of Washington, United States

    1 publications · 17 citations

    1

    h-index

  5. JB
    John Boyce

    SUNY Downstate Health Sciences University, United States

    1 publications · 29 citations

    1

    h-index

1–5 of 292

Institutions

113

  1. Brigham and Women's Hospital

    Boston, United States

    4 h-index

    17 publications

    734 citations

  2. Harvard University

    Cambridge, United States

    4 h-index

    14 publications

    483 citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    12 publications

    1.1K citations

  4. Dana-Farber Brigham Cancer Center

    Boston, United States

    2 h-index

    10 publications

    410 citations

  5. University of California, San Francisco

    San Francisco, United States

    2 h-index

    7 publications

    1K citations

  6. Hammersmith Hospital

    London, United Kingdom

    2 h-index

    11 publications

    1.8K citations

  7. University of Pennsylvania

    Philadelphia, United States

    2 h-index

    17 publications

    481 citations

  8. Fox Chase Cancer Center

    Philadelphia, United States

    2 h-index

    2 publications

    91 citations

1–8 of 113

Venues

  1. Gynecologic Oncology

    9 publications · 548 citations

    9

    h-index

  2. Annals of Surgical Oncology

    3 publications · 245 citations

    3

    h-index

  3. Blood

    3 publications · 405 citations

    3

    h-index

  4. American Journal of Obstetrics and Gynecology

    AJOG · 2 publications · 71 citations

    2

    h-index

  5. PubMed

    Repository · 2 publications · 55 citations

    2

    h-index

1–5